関連する実験動画
Updated: Sep 9, 2025
05:56
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
2.2K
集中治療室に収容された免疫炎症疾患の患者における致死性の予測要因
Natalia N Abramova1, Ilia S Avrusin2, Olga P Kozlova3
1Department of Anesthesiology, Resuscitation and Emergency Pediatrics, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Russia.
World journal of critical care medicine
|August 29, 2025
まとめ
免疫炎症性疾患を患っている高リスク患者の早期発見は極めて重要です. 組織的なリウマティック疾患と長時間集中治療室 (ICU) の滞在は,子供における致命的な結果の主要な予測因子です.
科学分野:
- 小児重症治療薬
- 免疫炎症性疾患
- リウマトロジ
背景:
- システム性免疫炎症疾患は重大なリスクをもたらし,しばしば重症病棟 (ICU) の入院が必要になります.
- マルチシステム炎症症症候群や全身性赤血性狼のような疾患はしばしばICUの治療を必要とし,影響を受けた小児の脆弱性を強調しています.
研究 の 目的:
- 免疫炎症疾患でICUに入院した小児患者の早期死亡予測要因を特定する.
- この研究は リスクの階層化を改善し,重症児の臨床管理を導くことを目的としています.
主な方法:
- 2007年から2023年の間にICUに入院した様々な免疫炎症疾患を有する51人の小児患者を分析したレトロスペクティブコホート研究.
- データには,患者の人口統計,疾患タイプ,治療歴,ICU滞在期間,およびアウトカムが含まれていました.
主要な成果:
- 全体として,ICUでの滞在中に患者の25.5%が死亡しました.
- 死因の主要な予測要因には,高齢者,ICU入院の遅延,前回の免疫抑制療法,侵襲性菌根症,全身性リウマチ病,ICU滞在の延長 (> 15 日) が含まれていた.
- 多重回帰では,全身性リウマティック疾患と15日を超えるICU滞在が死亡率の最も強い予測要因として特定されました.
結論:
- 免疫炎症性疾患の小児患者の死亡リスクの重要な要因である.
- 標的型モニタリングと予防戦略,特に侵入性菌根症と,全身性リウマティック疾患の患者の長期ICU治療を回避することで,生存率を向上させることができます.
さらに関連する動画
関連する概念動画
01:26Factors Affecting the Risk of Infection
12.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.3K
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:29Acute Kidney Injury III: Clinical Manifestations
90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90
01:30Pneumonia III: Complications and Assessment
432
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
432
01:29Acute Respiratory Failure-V
203
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
203
01:22Myocarditis IV: Nursing Management
26
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
26